Home | Welcome to Contract Pharma   
Last Updated Friday, September 19 2014
Print

Ranbaxy Begins Atorvastatin Recall



Published November 29, 2012
Related Searches: tablets Dosage
Ranbaxy, Inc., a subsidiary of India’s Ranbaxy Laboratories Ltd., has initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg), a generic of Pfizer’s Lipitor. The voluntary action is being taken as a precautionary measure due to the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand.
 
On November 23rd, Ranbaxy posted a notice of the recall on its U.S. website, covering 10 mg, 20 mg and 40 mg doses of tablets of atorvastatin calcium, but not the 80 mg dosage. "Ranbaxy is proactively recalling the drug product lots out of an abundance of caution," the website statement read. "This recall is being conducted with the full knowledge of the U.S. FDA."
 
According to the company, the probability of an adverse event due to consumption of this product is unlikely but cannot be ruled out. To date, the company has not received any reports of adverse events related to this recall.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On